Accessible Synthesis of the Tricyclic Core of Forskolin as an Adenylyl Cyclase Activator against Cellular Senescence
CSEF · 2023 Chemistry Third Award
Overview
Cellular senescence is the singular most significant risk factor in disease pathogenesis, particularly for chronic diseases including cancer, diabetes, disease, stroke, and dementia. Senescent cells naturally accumulate as time passes as aged cells permanently withdraw from the cell cycle, resulting in restricted stem cell function, increased base-level inflammation, and compromised tissue repair and regeneration. As such, here we present the synthesis of accessible small molecule nuclear reprogramming factors in an effort to combat cellular senescence, mitigating its widespread effects. While historically, most of medicinal chemistry efforts have focused on the development of inhibitors, the therapeutic value of small molecule based pathway activators is underrepresented. One such molecule derived from nature is forskolin, a labdane diterpenoid derived from the plant Coleus barbatus. Forskolin has been identified as a small molecule adenylyl cyclase activator, triggering transcription cascades through increasing levels of intracellular cAMP, which has implications in regenerative therapeutics. Currently, this compound is difficult to source from nature and is costly to isolate. Its total synthesis is complicated by its heavily oxygenated and polyfunctionalized carbocyclic core. To date, the shortest total synthesis of forskolin proceeds through 24 steps. Moreover, the exact contribution of the many oxidation functionalities of this compound, including the C1 hydroxyl and C9 hydroxyl groups, has not been fully established. Thus here, we present an accessible synthetic route to the tricyclic core of the forskolin scaffold, enabled through a complexity building diels-alder reaction, as well as in silico studies toward deconvoluting the SAR of the forskolin scaffold.
Source coverage
This record comes from a published award list, not a complete project archive. Its abstract comes from CSEF's public project showcase as archived by the Internet Archive before judging (https://web.archive.org/web/20230401224130/https://ca-csef.zfairs.com/showcase/ShowcaseInfo?f=838e60b7-ea75-46e8-865c-fde4864244b3); the version presented may differ.
Awards (1)
Competition history
- CSEF 2023
Resources
Related projects
ISEF · 2021
Towards the Total Synthesis of the TRAIL-Resistance-Overcoming Cytotoxic Pannokin D for the Development of New Anticancer Pharmaceuticals and a Novel Regioselective Diprenylated Chromone-Derived Flavonoid Synthesis
ISEF · 2024
The Secrets of Healthy Aging: Semi-Automated Discovery of Natural Senolytics
ISEF · 2022
Towards the Total Synthesis of the TRAIL-Resistance-Overcoming Pannokin D for the Development of a Pharmaceutically Significant Diprenylated Chromone-Derived Flavonoid Synthesis
ISEF · 2014
Toward a Total Synthesis of Novel Anti-Cancer Drimentine C
ISEF · 2024
Identification of Survivin as a Novel Longevity Biomarker: Towards Developing Novel Anti-Aging Therapeutics
AJAS · 2018
Synthesis of Boron-Based Natural Products as Anti-Cancer Agents
ISEF · 2024
Design, Synthesis and Biological Evaluation of a Hybrid Boronic Acid-Quinolinone Derivative as a Novel Acid Ceramidase Inhibitor To Target Breast Cancer
ISEF · 2015
DZ3: A Novel Analog that Selectively Targets and Eliminates Senescent Cells
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects